P1.02-04 the EGFR Resisters Lung Cancer Group: A Patient-Driven Initiative to Understand and Improve Treatments for EGFR+ Lung Cancer
Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.674
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV